CAR-T Cell Therapy In Cancer Clinical Trials Manufacturing Regulations & Clinical Delivery Course.

Aims: This course offers a thorough exploration of CAR-T cell therapies (Chimeric Antigen Receptor T cell) within the realm of clinical trials. Participants will delve into the historical background of CAR-T therapies, their classifications, regulatory frameworks, safety considerations, mechanisms of action, and the role of viral vectors. Additionally, the course emphasizes Good Manufacturing Practice (GMP), addressing essential considerations, manufacturing processes, and quality control. By the end of the course, participants will have a solid understanding of CAR-T therapies in the context of clinical trials, including practical insights into managing CAR-T cell therapy trials and an overview of their clinical implementation.

The course will provide delegates an excellent opportunity to network with scientists and trial managers from the UCL CAR-T Programme, the most comprehensive programme in Europe to manufacture and deliver CAR-T cell therapies across a broad study portfolio.